Phosenamine

Generic name:hyoscyamine sulfate, methenamine, phenyl salicylate, sodium phosphate, monobasic, monohydrate and methylene blue
Dosage form: capsule
Drug class:Urinary antispasmodics

Medically reviewed by Drugs.com. Last updated on Nov 22, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Phosenamine Description

Each capsule for oral administration contains:
Hyoscyamine Sulfate .12 mg
Methenamine 120 mg
Phenyl Salicylate 36 mg
Sodium Phosphate Monobasic 40.8 mg
Methylene Blue 10 mg

Inactive Ingredients: Dicalcium Phosphate, FD&C Blue #1, FD&C Red #3, Gelatin, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid, Titanium Dioxide, Shellac, Propylene Glycol, Sodium Hydroxide, Povidone.

Indications and Usage for Phosenamine

Phosenamine is indicated for the relief of discomfort of the urinary tract resulting from irritative voiding, diagnostic procedures, hypermotility, inflammation, and/or certain types of lower urinary tract infections.

Phosenamine Dosage and Administration

FOR ORAL USE ONLY
Adults: One capsule 4 times per day by mouth, followed by liberal fluid intake.
Older Children: Dosage must be individualized by physician.
Not recommended for use in children younger than six years.

Contraindications

Phosenamine is contraindicated in patients hypersensitive to any of its ingredients. Risk benefits should be carefully considered when the following medical problems exist: achalasia of esophagus, atony of colon, diseases of cardiovascular system, gastrointestinal hemorrhage; claucoma; hemolytic anemia from pyruvate kinase and G6PD deficiencies, infected urolithiasis, myasthenia gravis, paralytic ileus, severe ulcerative colitis, toxic megacolon; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

Warnings and Precautions

Do not exceed recommended dosage.